What one share of Editas Medicine holds
We are a pioneering gene editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The promise of genomic medicines is supported by the advancing knowledge of the human genome and by harnessing the progress in technologies for cell therapy, gene therapy, and, most recently, gene editing.
Editas Medicine’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.47 |
|---|---|
| Profit | −$0.73 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$1.19 |
| Cash and investments | $2.16 |
| Debt | $0.57 |
| Book value | $1.08 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2014 | — | −$12.46 | $1.08 | −$8.79 | — | −$13.62 |
| 2015 | — | −$28.55 | $0.56 | −$2.68 | — | −$25.70 |
| 2016 | $0.19 | −$3.02 | $0.11 | −$1.67 | — | $3.76 |
| 2017 | $0.34 | −$2.98 | $0.05 | −$0.28 | — | $4.68 |
| 2018 | $0.68 | −$2.33 | $0.10 | −$1.07 | — | $4.84 |
| 2019 | $0.41 | −$2.68 | $0.12 | −$0.94 | — | $4.83 |
| 2020 | $1.55 | −$1.98 | $0.12 | −$3.19 | — | $6.29 |
| 2021 | $0.38 | −$2.85 | $0.12 | −$2.54 | — | $8.09 |
| 2022 | $0.29 | −$3.21 | $0.06 | −$2.64 | — | $5.24 |
| 2023 | $1.03 | −$2.02 | $0.06 | −$1.80 | — | $4.27 |
| 2024 | $0.39 | −$2.88 | $0.11 | −$2.66 | — | $1.62 |
| 2025 | $0.46 | −$1.80 | $0.01 | −$1.87 | — | $0.28 |
Common questions about Editas Medicine
How much does one share of Editas Medicine earn?
Over the last 12 months, Editas Medicine lost $0.73 for each share on $0.47 of sales.
Does Editas Medicine pay a dividend?
Editas Medicine didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Editas Medicine’s book value per share?
Editas Medicine’s book value is $1.08 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Editas Medicine have?
Each share of Editas Medicine has $2.16 of cash and investments and $0.57 of debt, as of June 30, 2026.
What is Editas Medicine’s free cash flow per share?
−$1.19 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Editas Medicine bought back shares?
Editas Medicine’s share count rose about 7802% from 2014 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.